These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8315392)

  • 1. Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain.
    Hwu P; Shafer GE; Treisman J; Schindler DG; Gross G; Cowherd R; Rosenberg SA; Eshhar Z
    J Exp Med; 1993 Jul; 178(1):361-6. PubMed ID: 8315392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes.
    Hwu P; Yang JC; Cowherd R; Treisman J; Shafer GE; Eshhar Z; Rosenberg SA
    Cancer Res; 1995 Aug; 55(15):3369-73. PubMed ID: 7614473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression in cytotoxic T lymphocytes of a single-chain anti-carcinoembryonic antigen antibody. Redirected Fas ligand-mediated lysis of colon carcinoma.
    Darcy PK; Kershaw MH; Trapani JA; Smyth MJ
    Eur J Immunol; 1998 May; 28(5):1663-72. PubMed ID: 9603473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer.
    Peoples GE; Davey MP; Goedegebuure PS; Schoof DD; Eberlein TJ
    J Immunol; 1993 Nov; 151(10):5472-80. PubMed ID: 8228239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetic modification of T cells for cancer therapy: an overview of laboratory and clinical trials.
    Hwu P; Rosenberg SA
    Cancer Detect Prev; 1994; 18(1):43-50. PubMed ID: 8162605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional expression of chimeric receptor genes in human T cells.
    Eshhar Z; Waks T; Bendavid A; Schindler DG
    J Immunol Methods; 2001 Feb; 248(1-2):67-76. PubMed ID: 11223069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-infiltrating lymphocytes from human ovarian cancer patients recognize autologous tumor in an MHC class II-restricted fashion.
    Dadmarz RD; Ordoubadi A; Mixon A; Thompson CO; Barracchini KC; Hijazi YM; Steller MA; Rosenberg SA; Schwartzentruber DJ
    Cancer J Sci Am; 1996; 2(5):263-72. PubMed ID: 9166543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transduction of rIL-2 expanded CD4+ and CD8+ ovarian TIL-derived T cell lines with the G1Na (neor) replication-deficient retroviral vector.
    Nash MA; Platsoucas CD; Wong BY; Wong PM; Cottler-Fox M; Otto E; Freedman RS
    Hum Gene Ther; 1995 Nov; 6(11):1379-89. PubMed ID: 8573611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.
    Coney LR; Mezzanzanica D; Sanborn D; Casalini P; Colnaghi MI; Zurawski VR
    Cancer Res; 1994 May; 54(9):2448-55. PubMed ID: 7512887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
    Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
    Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of human colon cancer by T cells transduced with a chimeric receptor gene.
    Daly T; Royal RE; Kershaw MH; Treisman J; Wang G; Li W; Herlyn D; Eshhar Z; Hwu P
    Cancer Gene Ther; 2000 Feb; 7(2):284-91. PubMed ID: 10770638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single chain Ig/gamma gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic capacity.
    Weijtens ME; Willemsen RA; Valerio D; Stam K; Bolhuis RL
    J Immunol; 1996 Jul; 157(2):836-43. PubMed ID: 8752936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-2 expanded lymphocytes from lymph node and tumor biopsies of human renal cell carcinoma, breast and ovarian cancer.
    Bouet-Toussaint F; Genetel N; Rioux-Leclercq N; Bansard JY; Levêque J; Guillé F; Patard JJ; Lesimple T; Catros-Quemener V
    Eur Cytokine Netw; 2000 Jun; 11(2):217-24. PubMed ID: 10903800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel immunologic strategies in ovarian carcinoma.
    Freedman RS; Ioannides CG; Mathioudakis G; Platsoucas CD
    Am J Obstet Gynecol; 1992 Nov; 167(5):1470-8. PubMed ID: 1332480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy.
    Leisegang M; Turqueti-Neves A; Engels B; Blankenstein T; Schendel DJ; Uckert W; Noessner E
    Clin Cancer Res; 2010 Apr; 16(8):2333-43. PubMed ID: 20371691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study.
    Goedegebuure PS; Douville LM; Li H; Richmond GC; Schoof DD; Scavone M; Eberlein TJ
    J Clin Oncol; 1995 Aug; 13(8):1939-49. PubMed ID: 7636534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies.
    Pisa P; Halapi E; Pisa EK; Gerdin E; Hising C; Bucht A; Gerdin B; Kiessling R
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7708-12. PubMed ID: 1502188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicle-Stimulating Hormone Receptor as a Target in the Redirected T-cell Therapy for Cancer.
    Urbanska K; Stashwick C; Poussin M; Powell DJ
    Cancer Immunol Res; 2015 Oct; 3(10):1130-7. PubMed ID: 26112923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T lymphocytes engineered to express a CD16-chimeric antigen receptor redirect T-cell immune responses against immunoglobulin G-opsonized target cells.
    D'Aloia MM; Caratelli S; Palumbo C; Battella S; Arriga R; Lauro D; Palmieri G; Sconocchia G; Alimandi M
    Cytotherapy; 2016 Feb; 18(2):278-90. PubMed ID: 26705740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-idiotypic antibody facilitates scFv chimeric immune receptor gene transduction and clonal expansion of human lymphocytes for tumor therapy.
    Cheung NK; Guo HF; Modak S; Cheung IY
    Hybrid Hybridomics; 2003 Aug; 22(4):209-18. PubMed ID: 14511566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.